http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-38235-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-92
filingDate 1973-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1978-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-38235-B1
titleOfInvention Preparations for combatting swine dysentery
abstract 1386927 Treatment of swine dysentery F HOFFMANN-LA ROCHE & CO AG 14 Sept 1973 [15 Sept 1972] 43233/73 Heading A5B Swine dysentery is prevented and/or combatted by administration orally or parenterally of 1-methyl-2-isopropyl-5-nitroimidazole (ipronidazole) or a water-soluble pharmaceutically acceptable acid addition salt thereof to swine susceptible to or afflicted with swine dystentery. Hydrochloride and bisulphate salts of ipronidazole are preferred. The ipronidazole may be administered in the form of drinking water, feed or injectable solutions.n[GB1386927A]
priorityDate 1972-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496721

Total number of triples: 22.